Millennium Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Millennium Management’s Portfolio RETA Stock Details RETA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-150,600	Closed	-$5.72M	–	7160
2022 Q4	$5.72M	Buy	+150,600	New	+$5.18M	﹤0.01%	2695
2022 Q2	–	Sell	-40,600	Closed	-$1.33M	–	7725
2022 Q1	$1.33M	Buy	+40,600	New	+$1.2M	﹤0.01%	4266
2021 Q2	–	Sell	-25,000	Closed	-$2.49M	–	7306
2021 Q1	$2.49M	Buy	25,000 +18,200	+268%	+$2.12M	﹤0.01%	3318
2020 Q4	$841K	Sell	6,800 -10,000	-60%	-$1.31M	﹤0.01%	3844
2020 Q3	$1.64K	Buy	+16,800	New	+$2.1M	﹤0.01%	2752
2020 Q1	–	Sell	-19,000	Closed	-$3.88M	–	4688
2019 Q4	$3.88M	Buy	19,000 +2,000	+12%	+$365K	﹤0.01%	2135
2019 Q3	$1.36M	Buy	+17,000	New	+$1.44M	﹤0.01%	2676

Other funds holding RETA

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Millennium Management's RETA Position: Q3 2023 in Review

Millennium Management sold out of Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) in Q3 2023, closing a stake of 556,264 shares — an estimated $56.7M sold.

Millennium Management first reported a position in RETA in Q4 2016 and held it in 23 quarters. The position peaked at $56.7M in Q2 2023. 2 funds tracked by Wall St. Rank hold RETA as of Q3 2023.

Millennium Management reported no remaining Reata Pharmaceuticals, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
Millennium Management sold 556,264 Reata Pharmaceuticals, Inc. Class A Common Stock shares in Q3 2023, an estimated $56.7M.
Millennium Management first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q4 2016 and held it in 23 quarters.
Millennium Management's Reata Pharmaceuticals, Inc. Class A Common Stock position peaked at $56.7M in Q2 2023.
2 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q3 2023.

Based on Millennium Management's 13F filing for Q3 2023, filed 14 Nov 2023.